Abstract:Abstract Motivation Drug combination therapy has become an increasingly promising method in the treatment of cancer. However, the number of possible drug combinations is so huge that it is hard to screen synergistic drug combinations through wet-lab experiments. Therefore, computational screening has become an important way to prioritize drug combinations. Graph neural network has recently shown remarkable performance in the prediction of compound–protein interactions, but it has not been applied to the screening of drug combinations. Results In this paper, we proposed a deep learning model based on graph neural network and attention mechanism to identify drug combinations that can effectively inhibit the viability of specific cancer cells. The feature embeddings of drug molecule structure and gene expression profiles were taken as input to multilayer feedforward neural network to identify the synergistic drug combinations. We compared DeepDDS (Deep Learning for Drug–Drug Synergy prediction) with classical machine learning methods and other deep learning-based methods on benchmark data set, and the leave-one-out experimental results showed that DeepDDS achieved better performance than competitive methods. Also, on an independent test set released by well-known pharmaceutical enterprise AstraZeneca, DeepDDS was superior to competitive methods by more than 16% predictive precision. Furthermore, we explored the interpretability of the graph attention network and found the correlation matrix of atomic features revealed important chemical substructures of drugs. We believed that DeepDDS is an effective tool that prioritized synergistic drug combinations for further wet-lab experiment validation. Availability and implementation Source code and data are available at https://github.com/Sinwang404/DeepDDS/tree/master

DMSDR: Drug Molecule Synergy-Enhanced Network for Drug Recommendation with Multi-source Domain Knowledge

Leveraging Multiple Types of Domain Knowledge for Safe and Effective Drug Recommendation.

MFSynDCP: multi-source feature collaborative interactive learning for drug combination synergy prediction

MDNNSyn: A Multi-Modal Deep Learning Framework for Drug Synergy Prediction

MMSyn: A New Multimodal Deep Learning Framework for Enhanced Prediction of Synergistic Drug Combinations

An In Silico Method for Predicting Drug Synergy Based on Multitask Learning

DEML: Drug Synergy and Interaction Prediction Using Ensemble-Based Multi-Task Learning

MoleRec: Combinatorial Drug Recommendation with Substructure-Aware Molecular Representation Learning

Synergizing Convolutional Neural Networks and Drug Similarity Estimation for Improved Drug-Drug Interaction Prediction

DDoS: A Graph Neural Network based Drug Synergy Prediction Algorithm

Molecular Substructure-Aware Network for Drug-Drug Interaction Prediction

DrugSK: A Stacked Ensemble Learning Framework for Predicting Drug Combinations of Multiple Diseases

DKPE-GraphSYN: a drug synergy prediction model based on joint dual kernel density estimation and positional encoding for graph representation

MSDSE: Predicting drug-side effects based on multi-scale features and deep multi-structure neural network

DeepDDS: deep graph neural network with attention mechanism to predict synergistic drug combinations

Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning

DTSyn: a Dual-Transformer-based Neural Network to Predict Synergistic Drug Combinations

Synergistic Multi-Drug Combination Prediction Based on Heterogeneous Network Representation Learning with Contrastive Learning

KMR: Knowledge-Oriented Medicine Representation Learning for Drug-Drug Interaction and Similarity Computation.

A multi-task learning model for predicting drugs combination synergy by analyzing drug-drug interactions and integrated multi-view graph data

Drug-Target Interaction Prediction Based on Multi-Similarity Fusion and Sparse Dual-Graph Regularized Matrix Factorization.